Blog Archives

Clinician Versus Machine: Reliability and Responsiveness of Motor Endpoints in Parkinson’s Disease

D. Heldman, A. Espay, P. Lewitt, and J. Giuffrida Parkinsonism Relat Disord. 2014;20(6):590–5.


PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess motor symptoms in response to new deep brain stimulation (DBS)

Read more ›


PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The study, funded by the National Institutes

Read more ›


The Modified Bradykinesia Rating Scale for Parkinson’s disease: Reliability and Comparison with Kinematic Measures

D. Heldman, J. Giuffrida, R. Chen, M. Payne, F. Mazzella, A. Duker, A. Sahay, S. Kim, F. Revilla, A. Espay. Mov Disord. 2011 Aug 15;26(10):1859-63


PRESS RELEASE: CLEVEMED ISSUES ONLINE UPDRS SCORING CHALLENGE TO HIGHLIGHT BENEFITS OF KINESIA™ AUTOMATED TREMOR SCORING

VIEW PRESS RELEASE [PDF] CLEVELAND, Ohio (March 24, 2009) – Cleveland Medical Devices Inc. (CleveMed) announced the release of automated tremor scoring for Kinesia™, a compact patient worn device for assessing Parkinson’s disease (PD) motor symptom severity. To demonstrate the benefits of Kinesia and the new tremor scoring feature, CleveMed

Read more ›


PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE

VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment stimulator programming in deep brain stimulation (DBS) procedures for Parkinson´s

Read more ›


Comparison of Kinesia to the Unified Parkinson’s Disease Rating Scale: Tremor and Bradykinesia Results

D. Heldman, Ph.D., David E. Riley, M.D., Brian N. Maddux, M.D., Ph.D.,J. Giuffrida, Ph.D. Presented at the 2008 American Academy of Neurology Annual Meeting